Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents
Methylenetetrahydrofolate reductase homozygosis and low-density lipoproteins in patients with genotype 1 chronic hepatitis C
Role of Helicobacter pylori in patients with HCV-related chronic hepatitis and cirrhosis with or without hepatocellular carcinoma: possible association with disease progression
Assessment of factors associated with pre-diabetes in HCV infection including direct and dynamic measurements of insulin action
The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1–infected patients treated with Peg-IFN-alfa-2a and ribavirin
Evolution of biomarkers of liver fibrosis and liver insufficiency in hepatitis C virus-infected patients treated with pegylated interferon plus ribavirin and rituximab
Cytokine profiles in high risk injection drug users suggests innate as opposed to adaptive immunity in apparent resistance to hepatitis C virus infection
Role of monokine induced by interferon-γ in liver injury induced by hepatitis B virus in mice
Maternal HBsAg status and infant size – a Faustian bargain?